Literature DB >> 30104153

Innate lymphoid cells in organ fibrosis.

Yohei Mikami1, Yoshiaki Takada2, Yuya Hagihara2, Takanori Kanai3.   

Abstract

Innate lymphoid cells (ILCs) are a recently identified family of lymphoid effector cells. ILCs are mainly clustered into 3 groups based on their unique cytokine profiles and transcription factors typically attributed to the subsets of T helper cells. ILCs have a critical role in the mucosal immune response through promptly responding to pathogens and producing large amount of effector cytokines of type 1, 2, or 3 responses. In addition to the role of early immune responses against infections, ILCs, particularly group 2 ILCs (ILC2), have recently gained attention for modulating remodeling and fibrosis especially in the mucosal tissues. Herein, we overview the current knowledge in this area, highlighting roles of ILCs on fibrosis in the mucosal tissues, especially focusing on the gut and lung. We also discuss some new directions for future research by extrapolating from knowledge derived from studies on Th cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibrosis; Inflammatory bowel disease; Innate lymphoid cells; Mucosal immunology; Pulmonary fibrosis

Mesh:

Substances:

Year:  2018        PMID: 30104153     DOI: 10.1016/j.cytogfr.2018.07.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  12 in total

1.  ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure.

Authors:  Anja Schulz-Kuhnt; Vicky Greif; Kai Hildner; Lisa Knipfer; Michael Döbrönti; Sabine Zirlik; Florian Fuchs; Raja Atreya; Sebastian Zundler; Rocío López-Posadas; Clemens Neufert; Andreas Ramming; Alexander Kiefer; Anika Grüneboom; Erwin Strasser; Stefan Wirtz; Markus F Neurath; Imke Atreya
Journal:  Front Immunol       Date:  2020-05-07       Impact factor: 7.561

Review 2.  Psoriasis and Connective Tissue Diseases.

Authors:  Toshiyuki Yamamoto
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

3.  Group 2 Innate Lymphoid Cells Participate in Renal Fibrosis in Diabetic Kidney Disease Partly via TGF-β1 Signal Pathway.

Authors:  Cuiping Liu; Ludan Qin; Jingya Ding; Luping Zhou; Chenlin Gao; Ting Zhang; Man Guo; Wei Huang; Zongzhe Jiang; Yang Long; Yong Xu
Journal:  J Diabetes Res       Date:  2019-07-03       Impact factor: 4.011

Review 4.  Senescence in Pulmonary Fibrosis: Between Aging and Exposure.

Authors:  Alessandro Venosa
Journal:  Front Med (Lausanne)       Date:  2020-11-12

Review 5.  The Roles of Immune Cells in the Pathogenesis of Fibrosis.

Authors:  Enyu Huang; Na Peng; Fan Xiao; Dajun Hu; Xiaohui Wang; Liwei Lu
Journal:  Int J Mol Sci       Date:  2020-07-22       Impact factor: 5.923

Review 6.  Bacteriotherapy for inflammatory bowel disease.

Authors:  Yusuke Yoshimatsu; Yohei Mikami; Takanori Kanai
Journal:  Inflamm Regen       Date:  2021-01-13

Review 7.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

Review 8.  Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery.

Authors:  Kentaro Iwata; Yohei Mikami; Motohiko Kato; Naohisa Yahagi; Takanori Kanai
Journal:  Inflamm Regen       Date:  2021-07-14

Review 9.  Radiation-Induced Salivary Gland Dysfunction: Mechanisms, Therapeutics and Future Directions.

Authors:  Kimberly J Jasmer; Kristy E Gilman; Kevin Muñoz Forti; Gary A Weisman; Kirsten H Limesand
Journal:  J Clin Med       Date:  2020-12-18       Impact factor: 4.964

Review 10.  Functional Contribution and Targeted Migration of Group-2 Innate Lymphoid Cells in Inflammatory Lung Diseases: Being at the Right Place at the Right Time.

Authors:  Stefan Wirtz; Anja Schulz-Kuhnt; Markus F Neurath; Imke Atreya
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.